It is mainly expressed in cardiac and skeletal muscle cells, and mutations in the caveolin-3 gene (cav3) have been identified in human patients with different muscle diseases, including LGMD [107]. The gene discussed is CAV3; the disease is limb-girdle muscular dystrophy.